NCT04964895 2025-12-17
QSCO
University Hospital, Toulouse
Completed
Clinical Trials
9 trialsNCT05649306 2025-10-03
Gender Related Coping and Survivorship for Genitourinary Cancers
Johns Hopkins University
Recruiting
NCT06427824 2025-10-03
Comprehensive Geriatric Assessment (Tests) for Bladder Cancer Participants Undergoing Radical Cystectomy
University of Chicago
Phase NA Recruiting
NCT06955910 2025-07-10
Assessing Financial Toxicity Using the PROFFIT Questionnaire in Patients Treated With Mini-invasive Approach for Urological Malignancies.
Istituto Oncologico Veneto IRCCS
Recruiting
NCT02400944 2025-04-02
Determinants of Bladder Cancer Recurrence Study (The DETER Study)
Memorial Sloan Kettering Cancer Center
Active not recruiting
NCT04598724 2023-01-03
Addressing Barriers to Palliative Care Use in Bladder Cancer
H. Lee Moffitt Cancer Center and Research Institute
Completed
NCT01776138 2021-10-06
PORCH
UNC Lineberger Comprehensive Cancer Center
Completed
NCT01447199 2020-01-07
The Molecular Predisposition to Hereditary Nonpolyposis Colon Cancer (HNPCC)
M.D. Anderson Cancer Center
Unknown
NCT03106610 2018-05-24
Trial of Anti-PD-1 (Nivolumab) in Bladder Cancer Patients Recently Treated With Intravesical BCG Immunotherapy
M.D. Anderson Cancer Center
Phase 1 Terminated